Technology has made it possible for Stanford Medicine residents to continue learning and caring for patients safely during the COVID-19 era.
This fourth post in the Understanding UTIs series provides a guide to preparing for a visit with a health care provider for a urinary tract infection.
Going outside soon after waking — rather than hopping directly onto a video call — will help you sleep better, says a Stanford vision researcher.
A large percentage of COVID-19 deaths in the U.S. have occurred in nursing homes. In a podcast interview, a Stanford geriatrician explains why.
Stanford psychologist Sarah Adler offers tips for doctors on how to have more effective conversations about weight with their patients.
What's it like to go viral on Twitter? Stanford Medicine professor Keith Humphreys recently found out when he tweeted an insight about COVID-19.
Talking about weight with your doctor can be difficult. Stanford Health Care Chief of Staff Megan Mahoney shares how she approaches this subject.
The COVID-19 pandemic gives new relevance to a synthetic substance developed by Stanford researchers that could help respiratory patients breathe easier.
As COVID-19 restrictions begin to lift, Dean Lloyd Minor discusses the importance of safely re-engaging patients in preventive care.
In U.S. hospitals, the frequency of brain imaging for acute stroke patients dipped, suggesting hesitancy to seek medical care for non-COVID-19 conditions.
The third part in the Understanding UTIs series debunks seven myths about urinary tract infections and provides references for reliable health information.
A Stanford team is developing a bioscaffold that helps insulin-producing cells get enough oxygen when transplanted for diabetes treatment.
Stanford patient care leader Catherine Krna is inspired by clinicians during turbocharged COVID-19 response, and sees lasting benefit of telehealth surge.
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
Based on new technologies and improved understanding, physicians are no longer recommending routine use of radioprotective shields for X-ray procedures.